CLASS II Device recall · Reported 10 Jul 2019 · FDA Enforcement Report

Vitros 250 Chemistry System, Product recalled

Ortho-Clinical Diagnostics is recalling Vitros 250 Chemistry System, distributed nationwide in the US. The recall was initiated on 8 Apr 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots
Quantity recalled5020 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1933-2019
FDA event ID
82784
Recalling firm
Ortho-Clinical Diagnostics, Rochester, NY
Classification
Class II
Status
Terminated
Recall initiated
8 Apr 2019
FDA classified
3 Jul 2019
Reported
10 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Device type
Spinal Implants

Timeline

8 Apr 2019Recall initiated by company
3 Jul 2019Classified by FDA+86 days
10 Jul 2019Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential negative drift in Creatine Kinase (CK) results when used on the VITROS 250 and 350 Systems.

Product as listed by the FDA

VITROS 250 Chemistry System, Product Code 8132086, (UDI # 10758750004409) Product Usage: Performs discrete clinical tests on serum, urine, and cerebral spinal fluid specimens. Methodologies include colorimetric (CM), potentiometric (PM), rate (RT), and immuno-rate (IR) tests using multi-layered VITROS Slides.

Where it was distributed

US Nationwide Distribution

Nationwide

Questions about this recall

Why was it recalled?

Potential negative drift in Creatine Kinase (CK) results when used on the VITROS 250 and 350 Systems.

Which lots are affected?

All lots

Where was it sold?

US Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 82784

This product is part of a recall event; the main page for the event is Vitros 350 Chemistry System, Product recalled.

More recalls from Ortho-Clinical Diagnostics

All 311

Other Spinal Implants recalls

All 1,157